Reduced cardiac uptake and enhanced washout of123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies

Journal of Nuclear Medicine

Volumn 47, Issue 7, 2006, Pages 1099-1101

  Kashihara, Kenichi ^a   Ohno, Manabu ^a   Kawada, Sanami ^a   Okumura, Yoshihiro ^a  

^a OKAYAMA KYOKUTO HOSPITAL   (Japan)

Author keywords

Dementia with Lewy bodies; Myocardial MIBG scintigraphy; Parkinson's disease; Pure autonomic failure

Indexed keywords

METAIODOBENZYLGUANIDINE 1 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; (3 IODOBENZYL)GUANIDINE; RADIOACTIVE IODINE;

ARTICLE; AUTONOMIC DYSFUNCTION; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEMENTIA; HEART DENERVATION; HEART FUNCTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART SCINTISCANNING; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; NERVE ENDING; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; SYMPATHETIC NERVE; AGED; AUTONOMIC NEUROPATHY; DIFFUSE LEWY BODY DISEASE; FEMALE; HEART MUSCLE; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; DEMENTIA; FEMALE; HUMANS; IODINE RADIOISOTOPES; LEWY BODY DISEASE; MALE; MIDDLE AGED; MYOCARDIUM; PARKINSON DISEASE; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS;

EID: 33747088256     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. 123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst. 1994;49:81-84.
2. Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta iodo benzyl guanidine myocardial scintigraphy. J Neurol Sci. 1998;155:60-67.
3. 123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology. 1999;53:1020-1025.
4. Yoshita M, Taki J, Yamada M. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2001;71:583-588.
5. Hague K, Lento P, Morgello S, et al. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol (Berl). 1997;94:192-196.
6. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies. Neurology. 2005;65:1863-1872.
7. Yoshida M, Fukumoto Y, Kuroda Y, et al. Sympathetic denervation of myocardium demonstrated by MIBG scintigraphy in pure progressive autonomic failure. Eur Neurol. 1997;38:291-296.
8. Gibb WR, Lees AJ. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol. 1989;15:27-44.
9. Kumar R, Bergeron C, Pollanan MS, et al. Cortical-basal ganglionic degeneration. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. 3rd ed. Baltimore, MD: Williams and Wilkins; 1998:297-316.
10. Litvan I, Agid Y, Calne G, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1-9.
11. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res. 1998;8:359-362.
12. Kaufmann H, Nahm K, Purohit D, et al. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology. 2004;63:1093-1095.
13. 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders. Ann Nucl Med. 2004;18:453-461.